Gene Therapy Injection in One Eye Surprises Scientists by Improving Vision in Both
10th December 2020
In a landmark phase 3 clinical trial, the international team, coordinated by Dr. Patrick Yu-Wai-Man from the University of Cambridge and Dr. José-Alain Sahel from the University of Pittsburgh and Institut de la Vision, Paris, successfully treated 37 patients suffering from Leber hereditary optic neuropathy (LHON). Subject to further trials, the treatment could help thousands of people across the world to regain and retain some of their sight.
If the Corporate Media weren’t so focused on bashing Trump we might get some decent coverage of amazing news like this.